About Evrysdi Evrysdi is an SMN2-splicing modifier designed to increase functional SMN protein production. With the introduction of a new tablet formulation, Evrysdi now offers an alternative ...
A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device ...
The productivity gap in research widens as male researchers utilize AI more effectively. Targeted interventions are needed to ...
Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...
AB (market cap: $16.28M), a company in the development stage, provided insights into its Q4 2024 performance and future plans during its recent earnings call. The company is advancing its Neola ...
DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public ...
10h
Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStopâ„¢ ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback